Golden Green, Inc. Novavax Inc Transaction History

Golden Green, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$134.56 - $217.97 $949,724 - $1.54 Million	-7,058 Closed	0 $0
Q3 2021 Oct 08, 2021	BUY	$177.8 - $270.58 $1.25 Million - $1.91 Million	7,058 New	7,058 $1.46 Million
Q2 2021 Jul 14, 2021	SELL	$121.0 - $257.67 $381,513 - $812,433	-3,153 Closed	0 $0
Q1 2021 Apr 13, 2021	SELL	$112.98 - $319.93 $130,152 - $368,559	-1,152 Reduced 26.76%	3,153 $572,000
Q4 2020 Jan 25, 2021	BUY	$78.74 - $139.5 $338,975 - $600,547	4,305 New	4,305 $480,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Golden Green, Inc., based on Form 13F filings with the SEC.

Stay updated on Golden Green, Inc. with notifications on news.